SCHEMBL7513808

SCHEMBL7513808

CCC(CC(=O)CC(=O)O)N1CCCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA5A P35218 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA13 Q8N1Q1 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CA5B Q9Y2D0 1/20 0.53
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRM5 P08912 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
KMT2A Q03164 2/20 0.33
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10025246 0.81 LMNA (0.51) LMNACA12CA1CA2CA3
SCHEMBL12156956 0.78 LMNA (0.61) LMNACA12CA1CA2CA3
SCHEMBL8201977 0.75 LMNA (0.59) LMNACA12CA1CA2CA3
SCHEMBL19266698 0.75 LMNA (0.51) LMNACA12CA1CA2CA3
SCHEMBL11471687 0.75 LMNA (0.55) LMNACA12CA1CA2CA3
SCHEMBL14834787 0.73 LMNA (0.55) LMNACA12CA1CA2CA3
SCHEMBL2079098 0.72 LMNA (0.75) LMNACA12CA1CA2CA3
SCHEMBL1747843 0.72 LMNA (0.75) LMNACA12CA1CA2CA3
SCHEMBL1877216 0.72 LMNA (0.75) LMNACA12CA1CA2CA3
SCHEMBL14163977 0.72 LMNA (0.54) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003740-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGOISTS Abbott Laboratories (US) 2000-05-31 EP disclosed
WO-1999006397-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 1999-02-11 WO disclosed